Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
269
datasets available to search
ShareScore release 0.7.1
Dataset results
269 results for “IG”
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
ClinicalTrials.gov study NCT05695352. IPD Sharing: YES. Countries: 1. Publications: 25.
Study of Octanorm Subcutaneous IG in Patients With PID
ClinicalTrials.gov study NCT01888484. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)
ClinicalTrials.gov study NCT03624946. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
ClinicalTrials.gov study NCT04847141. IPD Sharing: NO. Countries: 1. Publications: 1.
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
ClinicalTrials.gov study NCT01773707. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Templates for FAIRness evaluation criteria - RDA-SHARC ig
<p>The SHARC Interest Group of the Research Data Alliance was established to improve research crediting and rewarding mechanisms for scientists who wish to organise their data (and material resources) for community sharing. This requires that data are findable and accessible on the Web, and comply with shared standards making them interoperable and reusable in alignment with the FAIR principles. It takes considerable time, energy, expertise and motivation. It is imperative to facilitate the processes to encourage scientists to share their data. To that aim, supporting FAIR principles compliance processes and increasing the human understanding of FAIRness criteria – i.e., promoting FAIRness literacy – and not only the machine-readability of the criteria, are critical steps in the data sharing process. Appropriate human-understandable criteria must be the first identified in the FAIRness assessment processes and roadmap. This document is a reusable template that aims to support FAIRification assessment with human understandable criteria. The level of compliance for each criterion can be used to prioritise the most appropriate and sufficient training, support and actions.</p>
Supplementary material 1 from: Lee G-E, Han T, Jeong J, Kim S-H, Park IG, Park H (2015) Molecular phylogeny of the genus Dicronocephalus (Coleoptera, Scarabaeidae, Cetoniinae) based on mtCOI and 16S rRNA genes. ZooKeys 501: 63-87. https://doi.org/10.3897/zookeys.501.8658
COI sequences dataset of Dicronocephalus species in this study.: Explanation note: This COI data includes 50 individual sequences of the examined Dicronocephalus species and subspecies in this study
Supplementary material 3 from: Lee G-E, Han T, Jeong J, Kim S-H, Park IG, Park H (2015) Molecular phylogeny of the genus Dicronocephalus (Coleoptera, Scarabaeidae, Cetoniinae) based on mtCOI and 16S rRNA genes. ZooKeys 501: 63-87. https://doi.org/10.3897/zookeys.501.8658
The combined dataset of COI and 16S rRNA of Dicronocephalus species in this study.: Explanation note: There is the concatenated sequences of COI and 16S rRNA genes correspondence with each sample.
Supplementary material 2 from: Lee G-E, Han T, Jeong J, Kim S-H, Park IG, Park H (2015) Molecular phylogeny of the genus Dicronocephalus (Coleoptera, Scarabaeidae, Cetoniinae) based on mtCOI and 16S rRNA genes. ZooKeys 501: 63-87. https://doi.org/10.3897/zookeys.501.8658
16S rRNA sequences data set of Dicronocephalus species in this study.: Explanation note: This 16S rRNA data includes 46 individual sequences of the examined Dicronocephalus species in this study.
The ztd estimated values from three models named Site-wise, Grid-wise, and GPT3 and the ztd reference values provided by IGS between 2016 and 2020.
<p>The data includes the zenith total delay (ztd) values computed by three models provided by the VMF data server, namely <strong>Site-wise, Grid-wise, and GPT3</strong>, for target stations during the period from 2016 to 2020, along with the corresponding ztd values extracted from <strong>IGS-ztd</strong> for the respective sites and epochs.</p> <p>These data are utilized for specific accuracy analysis and model evaluation.</p>
uct c-IG-01 19um D38mm
<p># Summary:</p> <p>.X-Ray micro-computed tomography (micro-CT) of a Boise Idaho Gray (IG) sample (a plug with 38 mm diameter), including both raw projection data and the final reconstruction, for resolution with voxel size of 19 μm.</p> <p>.The 3D image was generated with an X-Ray micro-CT Scanner version Xradia Versa 510 from Zeiss performed by A Pereira at the UFF micro-CT Facility.</p> <p>.For use of these data, please remember to cite the DOI of the Zenodo repository and relevant papers.</p> <p># Tomo Details:</p> <p>.Aquisition date: 2023-04-07</p> <p>.Voxel size: 19.0231 μm;</p> <p>.Camera Binning: 1;</p> <p>.Sample-source distance: 135 mm;</p> <p>.Sample-detector distance: 110 mm;</p> <p>.Optical magnification: 0.4X;</p> <p>.Filter: HE#4;</p> <p>.Beam energy: 160 kV;</p> <p>.Power: 10 W;</p> <p>.Current: 63 uA;</p> <p>.Exposure time: 12.0 sec;</p> <p>.Projections: 1601;</p> <p># Contents:</p> <p>.uct_c-IG-01_19um_16bits.zip</p> <p>.uct_c-IG-01_19um_1601p.txrm</p> <p>.uct_c-IG-01_19um_1601p_Drift.txrm</p>
uct c-IG-02 44um D38mm
<p># Summary:</p> <p>.X-Ray micro-computed tomography (micro-CT) of a Boise Idaho Gray (IG) sample (a plug with 38 mm diameter), including both raw projection data and the final reconstruction, for resolution with voxel size of 44 μm.</p> <p>.The 3D image was generated with an X-Ray micro-CT Scanner version Xradia Versa 510 from Zeiss performed by A Pereira at the UFF micro-CT Facility.</p> <p>.For use of these data, please remember to cite the DOI of the Zenodo repository and relevant papers.</p> <p># Tomo Details:</p> <p>.Aquisition date: 2023-04-06</p> <p>.Voxel size: 44.0615 μm;</p> <p>.Camera Binning: 2;</p> <p>.Sample-source distance: 194 mm;</p> <p>.Sample-detector distance: 110 mm;</p> <p>.Optical magnification: 0.4X;</p> <p>.Filter: HE#4;</p> <p>.Beam energy: 160 kV;</p> <p>.Power: 10 W;</p> <p>.Current: 63 uA;</p> <p>.Exposure time: 4.0 sec;</p> <p>.Projections: 1601p;</p> <p># Contents:</p> <p>.uct_c-IG-02_44um_16bits.zip</p> <p>.uct_c-IG-02_44um_1601p.txrm</p> <p>.uct_c-IG-02_44um_1601p_Drift.txrm</p>
AID overexpression leads to aggressive murine CLL and non-Ig mutations that mirror human neoplasms
<p></p><p>Most cancers become more dangerous by the outgrowth of malignant subclones with additional DNA mutations that favor proliferation or survival. Using chronic lymphocytic leukemia (CLL), a disease exemplary of this process, and a model for neoplasms in general, we created transgenic mice overexpressing the enzyme, activation-induced deaminase (AID), whose normal function is to induce DNA mutations in B lymphocytes. AID allows normal B lymphocytes to develop more effective immunoglobulin (Ig)-mediated immunity, but also is able to mutate non-Ig genes, predisposing to cancer. In chronic lymphocytic leukemia (CLL), AID expression correlates with poor prognosis suggesting a role for this enzyme in disease progression. Nevertheless, direct experimental evidence identifying the specific genes that are mutated by AID and indicating that those genes are associated with disease progression is not available. To address this point, we overexpressed Aicda in a murine model of CLL (Em-TCL1). Analyses of TCL1/AID mice demonstrate a role for AID in disease kinetics, CLL-cell proliferation, and the development of cancer-related target mutations with canonical AID signatures in non-Igs genes. Notably, our mouse models can accumulate mutations in the same genes that are mutated in human cancers. Moreover, some of these mutations occur at homologous positions, leading to identical or chemically-similar amino acid substitutions as in human CLL and lymphoma. Together, these findings support a direct link between aberrant AID activity and CLL driver mutations that are then selected for their oncogenic effects, whereby AID promotes aggressiveness in CLL and other B-cell neoplasms.</p><p></p>
IG. 6. Ordination diagram of PCA of the Patagonian bat assemblage for craniodental variables using A) data set not size-corrected; and B) data set size-corrected. Polygons include specimens from each species: H. macrotus (▲), H. magellanicus (), H. montanus (▲), L. varius (■), M. chiloensis (●), and T. brasiliensis (£). Vectors show the strengh of correlation of each variable with the plane of PC1 and PC2. See text for abbreviations in Ecomorphological diversity in the Patagonian assemblage of bats from Argentina
IG. 6. Ordination diagram of PCA of the Patagonian bat assemblage for craniodental variables using A) data set not size-corrected; and B) data set size-corrected. Polygons include specimens from each species: H. macrotus (▲), H. magellanicus (), H. montanus (▲), L. varius (■), M. chiloensis (●), and T. brasiliensis (£). Vectors show the strengh of correlation of each variable with the plane of PC1 and PC2. See text for abbreviations
Ig PRx in AECOPD: Pilot Study
ClinicalTrials.gov study NCT02690038. IPD Sharing: UNDECIDED. Countries: 1. Publications: 24.
Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)
ClinicalTrials.gov study NCT03183609. IPD Sharing: NO. Countries: 1. Publications: 1.
Subcutaneous Ig NextGen 16% in PID Patients
ClinicalTrials.gov study NCT00391131. IPD Sharing: Not stated. Countries: 2. Publications: 1.
IG vs ID Bitter Administration
ClinicalTrials.gov study NCT03985865. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1
ClinicalTrials.gov study NCT03018652. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
ClinicalTrials.gov study NCT03730129. IPD Sharing: NO. Countries: 1. Publications: 19.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.